Portolan Capital Management’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.7M Buy
197,863
+25,588
+15% +$7.42M 2.97% 3
2025
Q4
$50.9M Sell
172,275
-79,281
-32% -$23.9M 2.73% 4
2025
Q3
$62M Sell
251,556
-298,037
-54% -$60.1M 3.35% 5
2025
Q2
$85.8M Buy
549,593
+156,673
+40% +$16.7M 5.38% 1
2025
Q1
$31M Sell
392,920
-234,021
-37% -$24.8M 2.35% 9
2024
Q4
$57.9M Sell
626,941
-104,005
-14% -$8.14M 3.89% 2
2024
Q3
$37.4M Sell
730,946
-22,170
-3% -$1.15M 2.71% 5
2024
Q2
$43.2M Sell
753,116
-247,373
-25% -$12.5M 3.56% 2
2024
Q1
$45M Sell
1,000,489
-233,535
-19% -$8.86M 3.42% 2
2023
Q4
$36.1M Sell
1,234,024
-176,352
-13% -$4.69M 3.16% 3
2023
Q3
$34.6M Buy
1,410,376
+989,186
+235% +$20.2M 3.23% 4
2023
Q2
$6.11M Buy
+421,190
New +$5.21M 0.54% 55

Other funds holding CLS

Portolan Capital Management's CLS Position: Q1 2026 in Review

Portolan Capital Management increased its Celestica (CLS) stake by 15% in Q1 2026, buying an estimated $7.42M and bringing the position to 197,863 shares worth $55.7M. The position accounts for 2.97% of the portfolio, ranked #3.

Portolan Capital Management first reported a position in CLS in Q2 2023 and has held it in 12 quarters since. The position peaked at $85.8M in Q2 2025. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Portolan Capital Management held 197,863 shares of Celestica worth $55.7M as of Q1 2026.
  • Portolan Capital Management bought 25,588 Celestica shares in Q1 2026, an estimated $7.42M.
  • Celestica made up 2.97% of Portolan Capital Management's portfolio in Q1 2026, its #3 holding.
  • Portolan Capital Management first reported a position in Celestica in Q2 2023 and has held it in 12 quarters since.
  • Portolan Capital Management's Celestica position peaked at $85.8M in Q2 2025.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Portolan Capital Management's 13F filing for Q1 2026, filed 15 May 2026.